Facebook icon Twitter icon Forward icon

Vote for your diabetes hero

People have until the end of the month to select their diabetes heroes in the prestigious Quality in Diabetes Care (QiC) awards.

Voting closes for the Diabetes Healthcare Professional of the Year, Outstanding Educator in Diabetes and the QiC Diabetes People’s Award on Wednesday, August 31. To read more, click here.

Diabetes drug cost approaches £1 billion

More than £900 million was spent on diabetes drugs by the NHS last year, according to the Prescriptions Dispensed in the Community report. To read more, click here.

DT Survey: We want your opinions

The views of readers of The Diabetes Times are being sought as part of a new drive to further improve our service.

We have launched The Annual DT Readership Survey 2016 to get invaluable feedback and to ensure we are fully catering for our audience. Click here to take part. 

The Big Interview – Tarja Stenvall

Tarja Stenvall is the general manager for the Diabetes and Cardiovascular Business Unit and UK Country Chair for Sanofi.

She outlines what she feels are the biggest challenges in diabetes care and what she wants to see change. To read the interview, click here.

Tresiba® now available in Scotland

An alternative treatment to help improve glycaemic control for adults living with diabetes is now available in Scotland.

NHS Scotland can now prescribe Novo Nordisk’s Tresiba® (insulin degludec), to people with either type 1 or type 2 to help manage their blood sugar levels. To read more, click here

Type 2 prevention protein discovery

Targeting a protein could help to prevent the development of type 2 diabetes, scientists have found.

A new treatment for the condition could be in the pipeline after the discovery of MondoA, experts claim. To read more, click here.